Abstract
Invasive fungal diseases (IFD) are devastating opportunistic infections that result in significant morbidity and mortality in a broad range of pediatric patients, particularly those with a compromised immune system. Recognition can be difficult, with non specific clinical signs and symptoms or isolated fever frequently the only presenting features. A high index of clinical suspicion in patients at increased risk of IFD is therefore necessary, and this requires knowledge of the pediatric patient population at risk, additional predisposing factors within this population, and the clinical signs and symptoms of IFD. This review aims to summarize our current knowledge regarding the recognition and clinical presentation of IFD in neonates and children.
Original language | English |
---|---|
Pages (from-to) | S12-S21 |
Number of pages | 10 |
Journal | Journal of the Pediatric Infectious Diseases Society |
Volume | 6 |
Issue number | Suppl 1 |
Early online date | 31 Aug 2017 |
DOIs | |
Publication status | Published - Sept 2017 |
Bibliographical note
AW and JK are supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of AberdeenKeywords
- invasive fungal disease
- clinical presentation
- invasive aspergillosis
- invasive candidiasis
- pediatric patients